MSF Access Campaign
@msf_access
We advocate for access to & development of lifesaving medicines, tests & vaccines for people in MSF programmes & beyond. #MedicinesShouldntBeALuxury
ID: 39773339
http://www.msfaccess.org 13-05-2009 15:34:16
15,15K Tweet
25,25K Followers
1,1K Following
Major advance in the fight against #TB 🚨: Today, the World Health Organization (WHO) recommended four new, shorter, and more effective treatment regimens for curing drug-resistant TB. These treatments were studied in the endTB trial, led by PIH, MSF International & IRD Global. Read more: pih.org/press/major-ad…
Sign this petition calling on Gilead Sciences to make the #HIV drug #lenacapavir accessible for people in low- & middle-income countries. Right now it's sold in high-income countries for treatment at $42,000/yr! But generics could be made for just $40. ✍️ secure.avaaz.org/campaign/en/en…
Liposomal amphotericin B (LAmB) is a lifesaving medicine for many infectious diseases, but people in low- & middle-income countries lack access to it. MSF's Jessica Burry, @dndi & others address the access barriers in this The Lancet Global Health article. msfaccess.org/lancet-global-…
We & CSOs call on Gavi, the Vaccine Alliance & UNICEF to ensure affordable pricing of the #mpox vaccine + support Africa CDC's outbreak response coordination efforts in procuring & distributing vaccines doses - affordably, equitably & transparently. msfaccess.org/letter-csos-ca…
🚨 Must Read 🚨 MSF Access Campaign & HJI write about the groundbreaking CompComSA investigation on a key TB DRUG in 2023 (BDQ) -that led to evergreening patents AND price being dropped, benefiting not just SA. 📲 spotlightnsp.co.za/2024/08/30/com… Via Spotlight Treatment Action Group (TAG) Stop TB Partnership
Why does Danaher Corporation refuse to release the GeneXpert audit they promised to make public? Is it because tests cost less than they claim? Is it because they're just dilly-dallying while 100,000 people die of TB every MONTH? Regardless, it's unacceptable. msfaccess.org/hidden-costs-g…